If you have pneumonitis with Keytruda, your doctor might prescribe corticosteroid treatment for you. Additionally, your doctor may recommend that you temporarily or permanently stop taking Keytruda.

There isn't enough evidence to support the use of Merck & Co/MSD's Keytruda in combination with chemotherapy as a first-line treatment for advanced triple negative breast cancer, according to the ...

One specific type of viral exanthem that dermatologists have seen with COVID is a morbilliform rash, meaning a measles-like ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

The KEYNOTE-689 trial assessing Keytruda (pembrolizumab) for the perioperative treatment of newly diagnosed stage 3 or 4A, resected, locally advanced head and neck squamous cell carcinoma met its ...

While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing ...

"These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The ...

Muscle weakness and a skin rash are the main symptoms ... This information could help your doctor choose the right treatment. Chest X-ray. This can show whether your lungs are damaged, a possible ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

"These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...